VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic

VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing.

The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX) and Sofinnova Ventures.